These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5764800)

  • 1. [Peripheral hemodynamic criteria and blood flow stimulating vasoactive drugs in healthy persons and in patients with arterial obstruction of the extremities].
    Ehringer H
    Med Welt; 1969 Jan; 3():148-60. PubMed ID: 5764800
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observations with a new combination of peripheral vasodilating agents].
    Dameno G
    Minerva Cardioangiol; 1967 Mar; 15(5):357-9. PubMed ID: 5603842
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlations between reactive hyperemia and response to vasodilator agents in patients with obliterating arteriopathies of the lower limbs].
    Dabizzi RP; Fantini F; Cappelli G; Grandonico F
    Minerva Cardioangiol; 1970 May; 18(5):287-90. PubMed ID: 5515012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report on the clinical testing of Lamuran (I)].
    Steinorth G
    Med Welt; 1967 Sep; 35():2025-32 contd. PubMed ID: 5595993
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with Rauwolfia alkaloid raubasin (Lamuran) in arterial, venous and lymphatic circulation disorders].
    Brembach H
    Med Welt; 1970 Feb; 6():240-3. PubMed ID: 5524036
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of a new central and peripheral vaso-regulator therapeutic agent: DF 69].
    Laveant-Hebrard C; Camus JP
    Therapeutique; 1970 Oct; 46(8):805-6. PubMed ID: 4989868
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic changes after intravenous administration of ajmaline in cardiopathic patients].
    Knippel M; Brusoni B; Cadel A
    Boll Soc Ital Cardiol; 1971; 16(1):47-56. PubMed ID: 5104118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of clinical trials of raubasin].
    Weidinger P
    Med Welt; 1970 Mar; 10():403-8. PubMed ID: 4908367
    [No Abstract]   [Full Text] [Related]  

  • 9. [The influence of combined Rauwolfia-saluretic therapy on the hemodynamics of hypertensive patients].
    Heimsoth V; Hartmann F; Hundeshagen H
    Arch Klin Med; 1966; 212(3):237-50. PubMed ID: 5974124
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacodynamic effect of chelating agents on the peripheral and renal circulation of persons with healthy blood vessels and with vascular diseases].
    Hackel F; Graubitz M
    Z Gesamte Inn Med; 1969 Nov; 24(21):761-6. PubMed ID: 4983476
    [No Abstract]   [Full Text] [Related]  

  • 11. [Xylocaine--anti-arrhythmic activity, clinical tolerance and hemodynamic repercussions (comparison with ajamline)].
    Bernard R; Vainsel H; Lewinson H; Renta C; Cornil A
    G Ital Cardiol; 1972; 2(1):159-60. PubMed ID: 5011999
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases].
    Caesar K
    Med Welt; 1971 Apr; 14():559-62. PubMed ID: 5551942
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new Soviet-made hypotensive preparation, rauvakan].
    Stupnitskiĭ AA; Ishkov VI
    Klin Med (Mosk); 1974 Jul; 52(7):121-5. PubMed ID: 4603303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rheocencephalographic changes in cerebral vascular diseases in the aged treated with the association of Raubasine and ergot alkaloids].
    Pasoli CA; Mansoldo G
    Minerva Cardioangiol; 1970 Apr; 18(4):267-71. PubMed ID: 5423416
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodynamic effects of ethaverine hydrochloride in patients with peripheral vascular disease.
    Asby GR; Stein M; Conrad MC; Michie DD
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1096-100. PubMed ID: 4215620
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic structure of hypotensive effect in the treatment of elderly and old patients with arterial hypertension].
    Tokar' AV
    Klin Med (Mosk); 1974 Jul; 52(7):117-21. PubMed ID: 4848858
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of raubasine in treatment of peripheral arterious circulation disorders].
    Koch G; Eide M
    Med Klin; 1972 Nov; 67(46):1519-21. PubMed ID: 4265445
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and experimental study on the effect of magnesium compositum on the blood circulation of extremities and kidney hemodynamics in health subjects and patients with vascular diseases].
    Hackel F
    Z Gesamte Inn Med; 1970 Jul; 25(14):635-41. PubMed ID: 5516164
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the drug therapy of arterial blood circulation disorders].
    Braun W
    Med Klin; 1967 Aug; 62(34):1310-2. PubMed ID: 5593010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Collateral dilatation therapy in coronary and peripheral arterial occlusive diseases. Experimental and clinical experiences with 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride (BEN)].
    Nordeck H; Eichler K; Mulch R; Völker D
    Munch Med Wochenschr; 1971 Jul; 113(27):1006-11. PubMed ID: 5108693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.